Natco Pharma Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "NATCO announces final approval of its ANDA for Bosentan tablets".
Natco Pharma Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "NATCO announces final approval of its ANDA for Bosentan tablets".